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I.

I INTRODUCTION

A. Hi story and D1scussion of the Problem

1.

The Question of the Conversion of Patty Acids to Carbohydrate.
The ability of the animal body to produce a net synthesis

of fat from ingested carbohydrate has been a well-established
fact since the classical studies of Lawes and Gilbert
over a century ago.

(1, 2)

These investigators demonstrated by balance

experiments that animals deposited more fat than was fed in the
diet.

Further confirmation of the body's ability to transform

dietary carbohydrates into fat was provided by Schoenheirner and
Rittenberg's studies

(3)

in which deuterium was used as a tool to

measure the synthetic process.

The quantitative as well as the

qualitative aspects of this conversion were further studied by
Longerecker in 1939 (4).
However,
of this,

it is much more difficult to demonstrate the reverse

the net synthesis bj animal tissues of carbohydrate

from fatty acids or from products of their metabolism.

Though

there have been several claims that such a synthesis does occur,
the experimental evidence in general has been equivocal or open
to much criticism.

For every investigator who has claimed to

have demonstrated this conversion it seems there has been someone
else who has been unable to do so by using similar methods.
One of the earliest approaches to the problem of gluconeogenesis from fatty acids was the feeding of diets consisting
solely of fats and then examining the liver for signs of Increased

1

glycogen storage.

By such methods Takao (5), Burn and Ling (6)

and Magnusson (7) claimed large increases in liver glycogen.

In

contrast Bodey (8), Gregg (9) and Greisheimer (10) found little
or no increase.

The small increments in the latter experiments

could readily be accounted for by the glycerol content of the fats,
for the feeding of glycerol alone was found to produce a marked
increase in liver glycogen (10).
consistently elevated

Even if the liver glycogen were

in fat-fed animals it is not proof that the

glycogen came from fats per se---it might have come from protein
or from carbohydrates in other body tissues.
Other investigators have attempted to demonstrate by means
of low respiratory quotients that fat can be converted to
carbohydrate.

By feeding high-fat diets Hawley, Johnson and

Murlin (80) were able to produce respiratory quotients below 0.70
in humans and Hawley and Murlin
with a pig.

(81) were able to do the same

Likewise Lyon, Dunlop and Stewart

(82) found R. Q,.'s

as low as 0.59 in obese human subjects on reducing diets.

These

authors claim the low R. Q.'s obtained indicate a conversion of
fat to carbohydrate.

Their reasoning is as follows.

Since the

theoretical R. Q, for the oxidation of fat is 0.70 a non-protein
R. Q. of less than 0.70 means the body is retaining excess 02
to form oxygen-rich carbohydrate from fat.
However,

is an R. Q,.

gluconeogenesis from fat?

of less than 0.70 really proof of a
Apparently not, for as Mitchell points

out in his excellent review of the subject

(11) gluconeogenesis

from amino acids, desaturation of fatty acids and other inter¬
mediary oxidative reactions could also play a role in lowering
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the R. Q. below 0.70.

Also there are many errors In the correction

of R. Q.'s for protein metabolism,

one source of error being the

body's delay in excreting urinary nitrogen.

The nitrogen used

in the calculation of R. Q.’s often comes in part from the cata¬
bolism of food given the animal in the meal prior to the test
meal.

Also, an R. Q. greater than 0.70 does not prove fat is

not being converted to carbohydrate for a simultaneous oxidation
of sugar would elevate the R. Q.

Thus one cannot conclude

definitely whether or not fats can give rise to carbohydrates
by studying the respiratory quotients of animals.
Another approach has been that of liver perfusion studies.
By such methods Burn and Marks

(12) and Jost

(13) claimed to

be able to demonstrate the formation of carbohydrate in the
liver from fat.

However, Mitchell

(11) criticizes these

studies

and claims that the glycogen increment may have been due to
lactic acid formed while the experiments were being set up or
from glycerol liberated from the fats present in the liver tissue.
Gregg (14) in perfusion experiments with livers from fat-fed
cats and dogs could not demonstrate any support for the theory
of gluconeogenesis from fatty acids.
Some investigators have attempted to account quantitatively
for the sugar excreted in the urine of depancreatized dogs in
response to epinephrine injections.

By such methods Chaikoff

and Weber (18) concluded that in a few of their experiments the
extra urinary sugar produced in response to the injection of
epinephrine must have been derived in part from .fatty acids.
Yet in similar experiments Eollman, Mann and Wilhelmj
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(19)

could produce no evidence for the formation of

sugar from fat.

In recent years many investigators have attacked the
question of the conversion of fats to carbohydrates by means of
studies with radioisotopes of carbon.

In 194-3 Buchanan et al.

(20) fed carboxyl-labeled acetate, propionate and butyrate to
fasted rats and found radioactivity in the liver glycogen.

Here

for the first time was conclusive evidence that the carbon atoms
of short chain fatty acids can find their way into carbohydrate
molecules.

Strisower et al.

(21) demonstrated In 1951 that

G^-h

is found in the blood glucose of rats fed tripalmitin-6-C^'’ ,

a

long chain fatty acid.
The mechanisms by which labeled carbon atoms of fatty acids
find their way into carbohydrate molecules has been studied by
numerous investigators (22 - 28) using isotopes of carbon.
Their results indicate that the main pathway is the degradation
of fatty acids into 2-carbon fragments

(acetyl-CoA) which then

traverse the Kreb9s cycle and finally form glucose via the re¬
verse of the Embden - Meyerhof scheme of glycolysis.
Now that it has been demonstrated that labeled carbons of
fats find their way into carbohydrate molecules the question of
net synthesis of sugar from fats arises.

If it is assumed that

for every two carbons entering the Kreb’s cycle as acetyl-CoA
two carbon atoms must be evolved as C02 obviously no net synthesis
can take place.

However,

if substances other than acetate enter

the cycle they could give rise to the liberated C02 while the
carbons of acetate produced a net synthesis of carbohydrate.
Whether or not such substances actually enter the Kreb*s cycle
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can be determined by measuring the CO2 ratio (29) where
G^Op derived from acetate-l-C^
G^-2'02 derived from acetate-2-C-^

If acetic acid is the only substance entering the Kreb*s cycle
the CO2 ratio will equal 1.0 after approximately a dozen'turns
of the cycle.

This can be demonstrated as follows;

If one

traces the carbon atoms of CHy-^COOH (^designates a radioactive
atom) through the citric acid cycle it will be seen that no
labeled C02 is liberated after the first turn but that 100$
of the C-* is liberated as C**02 after the second revolution.
When C^Hy-COOH is fed into the citric acid cycle no labeled
COg is set free during either the first or second turns.
the third turn 50$ of the
4th turn

is liberated as

75% has been given off.

On

and after the

By the twelfth revolution

99.92>7o (29) of the labeled carbon ha.s taken the form of carbon
dioxide.

With each subsequent turn the liberated

C* approaches

closer to 100$ which is the value liberated when CHy-C*~00H was
fed into the cycle.

Hence the CO2 ratio approaches 1.0 after

several turns of the cycle.
If unlabeled substances enter the Kreb's cycle at the same
time as acetate-l-C-^ or acetate-2-C-*-^ they will dilute the
specific activities of the Kreb’s cjrcle intermediates.
et al.

Weinman

(29) demonstrate mathematically that this would produce

a CO2 ratio greater than 1.0 when the inflow and outflow of
labeled carbons has become constant.
Various investigators have made actual measurements of
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the C02 ratio by using fasted rats (30),

sheep Xactating mam¬

mary gland slices (31)» lactating qows (32) and rat liver slices
(33,

34).

The values obtained have ranged from 1,0 to 4.8.

Hence it would appear that acetate is not the only source of
carbon atoms entering the Kreb's cycle.

Presumably substances

such as glutamate and aspartate can enter the cycle by forming
alpha-ketoglutarate and oxaloacetate respectively.
proline, hydroxyproline, ornithine,

Likewise

arginine and histidine can

enter the cycle by first forming glutamate as a metabolic
breakdown product.
^1 so Weinman et al.

(29) point out that from various ex¬

perimental observations and thermodynamic considerations the
reaction

Oxaloacetate

+

ATP

Phosohopyruvate •* ALP + C02

proceeds more rapidly to the right than to the left, at least
in the mammalian liver.

Thus it would appear that fatty acids

can be degraded to 2-carbon acetyl fragments which can then
enter the Kreb's cycle to form oxaloacetate.

For each of these

acetyl fragments entering the cycle two carbons from substances
such as glutamate or aspartate are liberated as C02.

The oxalo¬

acetate then gives rise to a net synthesis of carbohydrate.

In

summary, for every two carbons of fat forming glucose two car¬
bons from another compound such as an amino acid must be uti¬
lized to maintain the Kreb's cycle.

Hence it is possible to

produce a synthesis of carbohydrate from fat via the Kreb's
cycle though such a synthesis is not the same as the net gain of
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fat from carbohydrate where a third substance (protein) is not
needed.

2„ Ketone Bodies and Their Relationship to the Glycogen Content
of the Heart and Other Tissues.
Not only ha.s there been much interest in the conversion of
fatty acids to sugar but also in the possible conversion of
ketone bodies --- acetoacetic acid, beta-hydroxybutyric acid
and acetone --- to glucose since they are products of fat cata¬
bolism.

Numerous investigators have demonstrated that aceto-

acetate arises largely by the recondensation of acetyl units
formed in the degradation of fatty acids but that a small amount
is formed from the beta-oxidation of butyric acid which is an
incomplete breakdown product of fatty acids (22, 35,
38,

39).

36,

37,

The utilization of acetoacetic acid in animal tissues

is commonly ascribed to two types of metabolic processes --reduction to beta-hydroxybutyric acid and oxidation to COg and
H2O after degradation to acetyl fragments.

The reduction and

its reversibility was first observed by Friedmann and Maase
(40) and Wakeman and Dakin (41).

Its oxidative breakdown was

demonstrated in experiments by Snapper and Grunbaum (42).

To

a small extent acetoacetic acid is decarboxylated to acetone
by animal tissues but Sakarni

(43) has ruled out acetoacetate as

the major source of acetone.
is not known.

The major precursor of acetone

Some evidence has been presented that it may

arise from leucine (44, 45).
Since acetoacetic acid or beta-hydroxybutyric acid is not
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readily utilized by the liver (46) but is readily assimilated by
striated muscle (47) arid by cardiac muscle

(48, 49) any con¬

version to glucose should be looked for in these extrahepatic
tissues,

Nagler (50) incubated surviving rat diaphragm in phos¬

phate buffer medium containing glucose (200 mgm./o), glucose and
insulin (0.05 unit per 1.0 ml), and glucose,
acetate (50 mgm./»).

insulin and aceto-

No effect of acetoacetate on glycogen

synthesis was observed.

Parnes and Wertheimer (51) and Chari

and Wertheimer (53) reported that acetoacetate depressed glycogen
synthesis in the rat diaphragm, even in the presence of insulin.
Nor has anyone else been able to demonstrate a conversion of
ketone to carbohydrate in striated muscle.
Of especial interest is the well extablished fact that
conditions producing ketosis in animals cause an increase in the
glycogen content of the myocardium.

Long and Evans found in

1932 (52) that fasted rats have a higher cardiac glycogen level
than fed animals.

In 1944 Lackey et al.

(54) found that rats

made diabetic with alloxan likewise had a significantly elevated
cardiac glycogen whereas the glycogen content of the liver and
skeletal muscle was decreased in comparison to control animals.
In 1945 Lackey, Bunde and Harris

(55) presented evidence

that there is no correlation between cardiac glycogen and blood
sugar or blood lactic acid levels but that there is a direct
correlation between the blood ketone level and heart glycogen in
rats under varied dietary conditions.

There was no relation¬

ship between the concentration of blood ketone bodies and liver
and muscle glycogen.

Later this same group of investigators
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(56)

infused fasted and fed rats with sodium acetoacetate and sodium
beta-hydroxybutyrate for four hours and found a marked increase
in cardiac glycogen in each case.

Of interest is the fact that

in the fasted rats a much higher blood ketone level was needed
to elevate the cardiac glycogen than in the case of the fed
animals.

Thus the blood ketone concentration does not appear

to be the only factor controlling the level of cardiac glycogen
in these experiments.
Since conditions producing ketosis unquestionably cause a
rise in cardiac glycogen the possibility of a direct conversion
of ketone bodies to glycogen in the heart naturally arises.
Stadie and Haugaard in 1947 (57) could not demonstrate any
glycogen synthesis in rat heart slices which were incubated with
sodium beta-hydroxybutyrate.

In 1956 Meyer and Bow (58) infused

rats with Na acetoacetate-3-C^4 and discovered no radioactivity
whatsoever in the cardiac glycogen after 2.5 hours of infusion
and concluded that "the net increase in heart carbohydrate
accompanying ketonemia represents some secondary and yet undetermined. influence of ketone bodies."
If there are any conditions under which the animal heart is
able to convert ketone bodies to glycogen what pathways might
be involved?

Following are possibilities that have frequently

been considered:
1) Acetoacetate
acetyl-CoA*“-»»— glucose via the
Kreb's cycle and the reverse of the Embden - Meyer¬
hof scheme of glycolysis.
2) Acetoacetate-“~#**”Qxalo&cetate —-^glucose by omega
oxidation of acetoacetate.
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3) Acetoacetate —butyrate*—»-» succinate-—•-oxaloacetate-—•—glucose by omega oxidation of butyrate
to succinate,
4) The Thunberg reaction, ie., the oxidative con¬
densation of two moles of acetate to succinate (59).
5)

(Acetoacetate —*■»>) acetone..^ pyruvate-*--^-glucose.

Meyer and Bow (60) perfused isolated dog’s hearts with Na
acetoacetate-t-G-^ and found malate and succinate to be labeled
almost exclusively in the carboxyl carbon which is compatible
with pathway 1) and not 2) or 3).

If 2) and 3) are mechanisms

utilized by the heart acetoacetate-3-C^ should label malate and
succinate in the methylene carbons.
3)

This was not the case.

is also unlikely in view of Lorber’s demonstration

(6l) that

butyrate is metabolized by animal tissues only in the conventional
manner --- beta-oxidation to 2 acetyl-CoA.

Meyer and Bow (60)

claim to have demonstrated the same thing in the isolated dog’s
heart in an unpublished observation.
Though Foster has presented evidence that the Thunberg
condensation does occur in the mold, Rhizopus nigricans,

(62,

63) the reaction has never been demonstrated satisfactorily in
animal tissues.
To a limited extent acetone gives rise to acetoacetate in
the liver of rats by earboxylation

(64).

Also the acetone

methyl carbon has been demonstrated to give rise to ’’formate",
probably by a 2- and 1-carbon cleavage in which acetate is
formed (43).

But does acetone produce a 3-carbon intermediate

of glycolysis such as pyruvate?

If it does acetone labeled in

the carbonyl position should label glucose according to the
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following equation:

CH^-C^O-C^-—^CH3-Ci40-C00H —■2, 5> 1, 6 -C14 glucose.

Metabolism of acetone by the carboxylation and cleavage
mechanisms should label glucose solely in the 3, 4 positions.
Accordingly Sakami and Lafaye (65) administered Cl4-carbonyllabeled acetone to rats and found higher activity in the 2, 5
than in the 1, 6 positions of glucose derived from liver gly¬
cogen.

Thus there is evidence that to a certain extent animal

tissues may be able to convert acetone to a 3-carbon intermediate
of glycolysis.

However,

it has already been pointed out that

acetone is not an important metabolic product of acetoacetate.
Thus it would seem that for the greatest part any conversion of
acetoacetate to glycogen in tissues under physiological con¬
ditions must follow the established pathway of beta-oxidation
to 2 acetyl-CoA which then traverses the Kreb's cycle.
already been pointed out,

As has

it is theoretically possible to pro¬

duce an actual synthesis of glycogen by this pathway.

X The Sffect of Growth Hormone on Cardiac Glycogen.
If the heart does not synthesize glycogen from ketone
bodies what is the explanation for the increased cardiac gly¬
cogen in animals with ketonemia?

Certainly it is not due to

increased insulin levels for insulin secretion is decreased in
diabetes.

Cruickshank and Startup concluded that the primary

defect in the diabetic heart is a failure to oxidize carbo¬
hydrate, presumable secondary to a lack of insulin
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(66).

Yet

is the increased cardiac glycogen in fasting animals due to
insulin deficiency?

Illingworth and Russell

(67) gave fasting

rats insulin and found no effect on the increased cardiac gly¬
cogen.

Bogue et al.

(68) concluded from studies on the dog

heart-lung preparation that glucose and not lactate was a source
of cardiac glycogen.

Yet Lackey, Bunde and Harris (55) could

find no correlation between cardiac glycogen levels and the
concentration of glucose in the blood.
In 1951 Illingworth and Russell (67) found that fasted rats
injected with growth hormone

(1-2 mgm./lOO 8m.) exhibited a

marked increase in cardiac glycogen as compared to fasted controls.
In 1956 Russell and Bloom (68) demonstrated that hypophysectomy
entirely prevented the increment in cardiac glycogen normally
observed in rats under fasting conditions, whereas the giving
of growth hormone to hypophysectomized fasted rats restored the
cardiac glycogen to the same levels seen in intact fasted con¬
trols.

Adrenalectomy did not significantly affect the cardiac

glycogen in either fasted or fed animals.

Hence the presence

of growth hormone appears essential to the production of the
rise in heart glycogen observed in the fasting state.

In unfasted

animals hypophysectomy produced no change in cardiac glycogen
or elevated it

slightly.

glucose growth hormone

In rats previously fasted and then fed

(1 mgm./lOO 8m.) not only prevented the

fall in cardiac glycogen normally observed under these con¬
ditions but caused it to rise above fasting levels.

Adrouny

and Russell (69) further demonstrated that growth hormone car
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simulate the effects of fasting on the heart glycogen when
given to fed animals and that feeding does not inhibit the ac¬
tivity of the hormone.

In summary it appears that fasting may

stimulate the secretion of growth hormone by the pituitary
and it may be that diabetes and other conditions producing
ketosis act likewise.
By what mechanism does growth hormone increase the gly¬
cogen content of the heart?

Russell and Bloom suggest three

possibilities:
1) Increased uptake of glucose from the blood.
2) Inhibition of utilization of stored glycogen.
3) Formation of glycogen from non-carbohydrate pre¬
cursors within the heart.
In view of the anabolic action of growth hormone it is unlikely
that it would produce gluconeogenesis from amino acids in the
heart.

Also there is no good evidence of the conversion of

fats to glycogen in the heart under physiological conditions.
Russell and Bloom point out that there is little evidence that
growth hormone increases uptake of glucose by other tissues
but that there is evidence that the hormone blocks carbohydrate
utilization.

Thus 2) would

seem the most likely8
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B. Purpose of the Present Investigation

Much evidence has been presented indicating that the heart
is unable to synthesize glycogen from ketone bodies.

Neverthe¬

less, the question is not completely settled for it is not yet
known whether a heart thoroughly depleted of its glycogen content
and then given a ketone body as the sole metabolite can resynthe¬
size glycogen.

Admittedly this is subjecting the heart to

rather unphysiological conditions.

However,

if carbohydrate is

essential to normal cardiac function and if the heart has any
enzyme system capable of producing gluconeogenesis from ketone
bodies it should become evident under such demanding circumstances.
Is there then a pathway, normally unused, by which the heart can
produce glycogen in an emergency?
Accordingly, the present investigation was undertaken to
determine if a heart so depleted of its glycogen can resynthesize
this carbohydrate from a ketone body, beta-hydroxybutyric acid.
The technique of heart perfusion seemed the best way to study
this problem.

The frog's heart was chosen because of the ease

with which it can be perfused and because its metabolism in many
ways is similar to that of the mammalian heart
Since Bogue et al.

(70, 76, 77, 78, 79).

(75) demonstrated quite conclusively that

the heart is able to synthesize glycogen from glucose it seemed
indicated to determine what effect,
on this conversion.

if any, ketone bodies have

If ketone bodies are not converted to

glycogen themselves do they increase the cardiac glycogen by
means of a sparing action on glucose?
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In other words,

can the

heart utilize ketone bodies for energy and thereby synthesize more
glycogen from glucose than would be the case if glucose were
present alone?
In view of the work by Russell et al.

(67? 68„

69)

demon¬

strating the glycogenic effect of growth hormone on heart muscle
it was also decided to study the influence of this hormone on
the possible synthesis of glycogen from ketones and from glucose
in a frog's heart first depleted of all of its glycogen.

Experi¬

ments to determine the effect of the hormone on cardiac glycogen
in the intact frog were also performed.
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II. MATERIALS AND METHODS

A. Animals —- American bullfrogs weighing 250 - 450 Gm. apiece
were used in the experiments*

Fresh shipments of frogs were

obtained and used every two weeks.

The animals were kept in

a fasting state at a temperature of approximately 4° C.
B. Equipment:
1. Desiccator jar used as anaerobic chamber.
2. Perfusion apparatus as described below.
C.

Chemicals used in depletion of cardiac glycogen and perfusion of
the heart.
1. Nembutal

(sodium pentobarbital).

2. Epinephrine -- 1:1000 concentration.
3. Glutathione -- reduced.
4. Beta-hydroxybutyric acid by Fisher Scientific Company.
5. Purified growth hormone made by Armour Laboratories.
6. Dextrose.
7. Physiological salt solution for perfusion as described by
Clark et al.
NaCl,

(70).

Solution consisted of:

0.65#

CaCl2, 0.024#
KC1,

0.015#

Na phosphate,

0.02# (pH * 7.6) in distilled H20.

8. Bottled oxygen and nitrogen gases.
D. Quantitative determination of tissue glycogen.
1. Chemicals:
a) KOH,

3# and 30#
16

b) EtCH, 95%
c) HC1, 2.5%
d) Phenol red, 1%
e) Copper Reagent. A
25.0 Gm./L
Rochelle salt

25.0 Gm./L

NaHCO-j

20.0 Gm./L

Ka2S0^

200.0 Gm./L

f) Copper Reagent B
Cu S04»5H2)

15/ with 1-2 gtts.

cone. HgSO^/lOOml.

g) Arseno Molybdate Soln.
Ammonium molybdate, 25 Gm.
H2SO4,

cone.

in 400 cc H^O.

21 cc.

Na2HAs04«7H20,

5 Gm. in 25 cc H2O.

Incubate at 37° for 24 - 48 hrs.
2. Methods:
The disintegration of tissue and hydrolysis of glycogen
to glucose were carried out according to the method of
Good, Kramer and Somo gyi

(71).

G-luco se was analyzed

by the method of Nelson (74).
E. Perfusion Apparatus;

The isolated beating heart was suspended

in a container of physiological solution by means of cannulas
inserted into the sinus venosus and into the two aortas.

It

was kept at a temperature of 25 - 27°C. by warm lights or
by surrounding its container with cool water, depending on
the room temperature.

Situated above the heart was a flask

containing the perfusate through which 02 bubbled.
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From this

flask the solution dripped into the cannula inserted in the
sinus venosus.
about 1 cm.

The heart then pumped it against a resistance of

of HpO into a second flask.

From here it was blown

by air under pressure back up to the first vessel.

Thus

the same solution could be recirculated through the heart as
many times as was desirable.
Adequate oxygenation was assured by the bubbling of O2
through the perfusate before it entered the heart and by
blowing the fluid back up to the first flask by pressurized air.
The resistance the heart pumped against was kept low to insure
as nearly complete emptying of the ventricle with each contraction
as was possible.
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III. EXPERIMENTAL PROCEDURE

A. Depletion of Cardiac Glycogen.

The frogs were injected intraperitoneally with approximately
20 mgm.

sodium pentobarbotal per 100 Gm. frog weight.

After

anesthesia occurred the heart was exposed by a ventral midline
incision opening the peritoneal and pleural cavities.

The ab¬

dominal and chest walls were reflected and the pericardium was
stripped from the heart, the circulation of blood being left intact.
The frog with its heart thus exposed and still beating was
placed, ventral side up in a desiccator jar.

The physiological

salt solution described in the previous section was allowed to
drip on the heart at a rate of 12 - 15 drops per minute from a
container placed within the desiccator.

Epinephrine was added to

this solution at a concentration of 1/500,000 to stimulate the
heart and a few mgm.

of reduced glutathione were used to keep the

epinephrine in a reduced state.

The air in the desiccator was

then displaced by 100/ nitrogen and the chamber sealed to make
it air tight.

The heart,

in situ in the frog and with isotonic

solution dripping on it to prevent drying:, continued to beat and
pump blood in this anaerobic atmosphere.
After 30 minutes to 4 hours,

sometimes longer,

in this

nitrogen-filled chamber a small area developed at the base of the
ventricle which appeared white in contrast to the red color of
the remaining myocardium.

If the preparation was then removed

to an aerobic atmosphere the white area of muscle disappeared
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but reappeared shortly when the heart was reintroduced into
the anaerobic chamber.

As the heart continued to beat anaero¬

bically the white area, which resembled scar tissue and did not
contract, enlarged continuously until it involved the entire
ventricle.

At this stage the ventricle could not be revived by

the introduction of oxygen.
When the white area which grossly re.sembled an old infarct
reached a size about 3X3 mm.

in area the entire ventricular

myocardium could be shown to be depleted of glycogen
"Results”).

The heart,

still contracting actively,

(see under
could then be

removed from the anaerobic chamber and perfused as a preparation
with ventricles free of glycogen.

All glycogen determinations

were carried out on viable ventricular myocardium not involved
by the "infarct"

(see "Discussion" for quotes).

The auricles

were not analyzed because of the difficulty in excluding sinus
venosus and aortic tissue from the specimen.

Also it would be

difficult to be certain the ratio of ventricular to auricular
tissue was the same each time.
perfused,

Hence, though the entire heart was

only the ventricles were analyzed for glycogen.

Only

hearts which developed the "infarct" were perfused though it was
found that some hearts became depleted
developed the white area.

of glycogen before they

Other hearts never developed the

scarred appearance until long after they had ceased beating from
exhau stion.

B. Berfusi on of the Heart.

Following the development of the "infarct" about 3 X 3 mm.
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in

area at the base of the ventricle the frog was removed from the
anaerobic chamber.

Immediately a glass cannula was inserted into

the sinus venosus and the blood washed from the heart with the
■physiological solution.

The two aortas were then cannulated with

polyethylene tubing and the heart removed from the frog and
attached to the perfusion apparatus.
with 400 cc.

The heart was then perfused

of the physiological salt solution to which had

been added substances such as glucose, beta-hydroxybutyric acid,
etc.

in known amounts.

All solutions were adjusted to a pH of 7.6.

After the heart had been perfused for the desired length of
time the ventricle, excluding the "infarcted1* portion, was removed,
blotted three times to remove excess fluid and dropped into a
weighed centrifuge tube containing 2cc. of 30% KOH.

The tube

was reweighed rapidly and then heated over an open flame to
disintegrate the tissue.
tatively.

Glycogen was then determined quanti¬

About 20 seconds elapsed from the time the ventricle

was cut from the auricles to the time it was disintegrated by
boiling.
In addition to the perfusions a set of in-vivo experiments
was performed in which fasting frogs were injected intraperitoneally with either growth hormone or saline.

The ventricles were then

analyzed for glycogen in the two groups of animals and the
re su11 s c ompared.
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IV. RESULTS

The results of this investigation are summarized in Tables
I to IV.

Table 1:
It should be noted that two types of controls were used for
the perfusion experiments.

The values listed in line 1 were

obtained on hearts removed from frogs under Nembutal anesthesia
with immediate determination of ventricular glycogen.

Thus the

value of 1238 i 74 mg$ represents the glycogen content of the
ventricles of frogs kept without food two weeks or less.

Though

not indicated on the table there was no correlation bet-ween the
level of cardiac glycogen and the duration of fasting within
this two week period.

However,

one frog sacrificed after three

months of fasting (not included in Table I) had a ventricular
glycogen content of 2450 mg%, more than 900 mg$ greater than that
of any frog in the same shipment kept less than two weeks.
fortunately,

Un¬

no other animals were kept for such an extended

period of time.
Line 2 of Table I demonstrates that hearts which were allowed
to beat in an anaerobic atmosphere until the 11 infarct" developed
and were then cannulated uniformly contained no glycogen in the
ventricles.

These hearts therefore serve as the controls for

hearts that were treated in the same manner but were then perfused
with various metabolites
and III).

(lines 3 - 6 of Table I and Tables II

It is obvious that the 15 to 20 minutes in an aerobic
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TABLE I

Determination of Glycogen Synthesis in Glycogen-Free Frog
Hearts Perfused with Glucose and Na Beta-hydroxybutyrate

Experiment

Number of
Animals

Ventricle
Glycogen
Mg>1

Duration of
Perfu sion
Hrs.

Controls:

1. Normal animal

12

2. After anaerobic period
and cannulation

7

1238 £ 74*

0 ± 0

0

0

Perfused with indicated
substance after depletion
of glycogen:

3.

4.

Sodium beta-hydroxy¬
butyrate, 100 mg/o

6

Sodium beta-hydroxy¬
butyrate, 25 fflg^

3

29 i 17

5 £ 4

4, 6, 12
See Table II

6

5. Glucose, 100 mg^

6

588 £ 81

6

6. Glucose, 100 mg% +
Sodium beta-hydroxy¬
butyrate, 100 mg%

6

595 ± 86

6

* Standard error as calculated from the formula

S. E.

N(N-1)»

where x eoxuals the difference between the mean and the experimenvalue and N is the number of experiments.
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atmosphere required for cannulation did not produce any glycogen
synthesis from possible products of glycogenolysis contained
within the heart muscle.
Line 5 demonstrates that hearts perfused with 100 mgm.
glucose per 100 cc. perfusate for six hours synthesized and
stored an amount of glycogen equal to 50% of the glycogen content
of the heart in an intact untreated animal (line 1),

The small

amount of glycogen synthesis indicated in the hearts perfused
with beta-hydroxybutyrate alone (lines 3 and 4) is of no signi¬
ficance in view of the relatively large standard error obtained.
Table I also indicates that whether hearts were perfused with
glucose alone or with glucose plus ketone, the same amount of
glycogen was formed.

Table II:
This table is an analysis of lines 3 and 4 of Table I.

Here

it can be seen that 7 of the 9 hearts perfused with ketone showed
no glycogen formation,

including the one perfused with 100 mgm.

per 100 cc. for twelve hours

(the values of 14 and 16 mg/2 are

well within the limits of error of the methods used to measure
glycogen and glucose).

That leaves a significant amount of

glycogen in only two of the nine hearts perfused with betahydroxybut-yric acid as the only metabolite.

The concentration

of ketone and the duration of perfusion were not significant.

Table III:
This table summarizes the results of studies to determine
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TABLE II

An Analysis of Lines 3 and 4 of Table I

Mg >1
Gone. of Sodium
Beta-hydroxybutyrate perfused.

Duration of
Perfusion
Hrs.

1

100

4

65

2

100

4

16

3

100

6

0

4

100

6

95

5

100

6

0

6

100

12

0

7

25

6

0

8

25

6

0

9

25

6

14

Experiment No.
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Ventricle
Glycogen
Mg/£

TABLE III

Effect of Growth Hormone on Glycogen Synthesis from Glucose and
Sodium Beta-Hydroxybutyrate in the Perfused Frog Heart

Number of
Animals

Ventricle
Glycogen
Mg#

3

435 t 158

6

3

548 i 21

6

3. Na beta-hydroxybutyrate,
100 mg# and
Growth hormone, 2 + 1+1 mg#*

3

166 1 40

6

4, Na beta-hydroxybutyrate,
100 mg#,
Growth hormone, 2+1+1 rag#*
and
Insulin, 2+2 units**-*-

3

100 i 44

6

5. Growth hormone, 2+1+1 mg#*

3

139 t 66

6

Experiment

Duration oJ
Perfu si on
Hrs.

Hearts perfused with indicated substance after depletion of glycogen:

1. Glucose, 100 mg# and
Growth hormone, 2 mg#

2, Glucose, 100 mg#,
Na beta-hydroxybutyrate,
100 mg# and
Growth hormone, 2 mg#

* 2 mg/o of growth hormone was added at the beginning of the per'
fusion and 1 mg# at the end of 2 and 4 hours.
** 2 units of insulin were added at the beginning of the perfusion
and 2 units at the end of 3 hours.
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the effect of growth hormone on glycogen synthesis in the perfused
heart.

All hearts were first depleted of glycogen by the method

previously described.

Unfortunately the number of experiments

performed in each case was small.
When one considers the large standard error of 158 mgy? in
line 1 of Table III there is no significant difference between
the value of 435 df 158 mg/e of ventricular glycogen obtained with
glucose and growth hormone and the 588 £ 81 mg/e shown in line 5
of Table I where glucose alone was perfused.

Likewise the value

obtained when growth hormone was added to ketone and glucose
(548 £ 21 mg%, line 2, Table III) is the same as the 595

86 mgfo

of glycogen synthesized from glucose and beta-hydroxybutyric
acid when the hormone was not present

(line 6, Table I).

hearts perfused with growth hormone alone

(line 5, Table III)

developed an average glycogen content of 139 — 66 mg%,
ketone

Three

Combining

(line 3» Table III) and ketone plus insulin (line 4, Table

III) with the growth hormone did not change the amount of glycogen
synthesized.

Table IV:
The results listed in this table demonstrate that frogs
injected, with 1.0 mgm. of growth hormone intraperitoneally at
0, 24 and 48 hours and sacrificed 8 hours later showed the same
amount of cardiac glycogen as suitable controls injected with
saline.

It should be noted that these control animals (line 1,

Table IV) have a much higher level of cardiac glycogen than the

animals in line 1, Table I ---2090^65 mg$ as compared to 1238 it 74 mg)o
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TABLE IV

Effect of Growth Hormone on Cardiac Glycogen of the Frog
In-Vivo

Experiment

Number of
Animals

Ventricle
Glycogen
Mg?b

3

2090 t 65

4

2018 t 144

Controls:

1. Fasting frogs injected intraperitoneally with 0.7 cc iso¬
tonic saline at 0, 24 and 48
hours and sacrificed 8 hours
after the last injection.

Experimentals:

2. Fasting frogs injected intraperitoneally with 1.0 mgm.
growth hormone per 100 Gms.
frog weight (0.7 cc total) at
0, 24 and 48 hours and sacri¬
ficed 8 hours after the last
injection,
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V. DISCUSSION

A.

Depletion of Cardiac

>gen:

It has long been known that anoxia rapidly lowers the glycogen
content of the myocardium (72, 73)®

In 1937 Bogue, Evans and

Gregory (75) demonstrated by means of the dog heart-lung
preparation that epinephrine can also deplete the heart of its
glycogen.

In the present series of experiments advantage was

taken of both of these methods to produce glycogenolysis.
However,

since the epinephrine was simply allowed to drip on the

external surface of the frog's heart it is questionable how
important a role it played in this respect.

Nevertheless,

it

did appear to strengthen the heart beat which would indicate
that it penetrated the muscle cells.
In the desiccator the perfusate of the heart was of course
the frog's own blood, the circulation having been left intact.
This method of depleting the heart's glycogen worked very well
except in a few instances where the flow of blood was sluggish,
usually due to hemorrhage in preparing the specimen.

In these

eases the heart would contract poorly and eventually stop.
Such specimens were discarded.
The nature of the white area that developed in the ventricles
after the period of anaerobiasis cannot be stated definitely
since histological studies were not performed.

It resembled an

old infarct resulting from coronary occlusion in the mammalian
heart in that it appeared ischemic and did not contra.ct.

29

However,

by strict definition an infarct is a local area of necrosis
resulting from vascular obstruction.

Since the frog has no

coronary arteries this was not strictly an infarct,
resulted from anoxia.

though it

Hence I use the word "infarct'* in this

modified sense and have put it in quotation marks.
In all the hearts analyzed the infarct

signaled that the

entire ventricular myocardium was depleted of glycogen.

In

general, the stronger and more rapid the contractions the
the infarct developed.

However,

sooner

occasionally a heart was found

that did not develop this area of necrosis even after many hours
of beating anaerobically,

even though it could be demonstrated

to be depleted of glycogen.

In summary then, all hearts

developing infarcts were found to be depleted of glycogen, though
the converse was not always true.
to beat though free of glycogen.

Thus hearts could continue
However, when such hearts were

perfused aerobically with only the physiological salt solution
they beat poorly,

often

stopping after an hour or two.

There¬

fore no control series of six hour perfusions with just the salt
solution could be carried out.

In contrast the addition of glucose

or ketones to the perfusate caused the hearts to beat

strongly

for long periods of time.
Clark et al,

(70) found that hearts containing glycogen would

beat for 24 hours or more with just the physiological salt
solution.

This would seem to indicate that muscle glycogen is

essential to normal cardiac function when no source of energy is
present in the perfusate such as ketone bodies,
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even though the

latter may rot give rise to glycogen.

£. Glycogen Levels in

Normal Frog' s Heart:

In the work by Clark et al.

(76) on the carbohydrate content

of the frog's heart it was found that the amount of glycogen
varied greatly in different batches of animals and in general was
higher in winter than in summer.

Also in one of his papers

Clark makes the statement that the carbohydrate content rose in
proportion to the time the frogs were kept in captivity.
it is not clear whether the animals were fed or not.

However*,

In the

present perfusion experiments these variations were overcome by
first depleting the hearts of all their glycogen.
However, the normal variability of the frog cardiac glycogen
probably plays a role in explaining the difference between the
1238 ir 74 mg% of ventricular glycogen in the control animals in
Table I and the 2090 + 65 mg/£ found in the controls in Table IV.
The frogs of line 1, Table I arrived in June and September, 1955
and the glycogen content was essentially the same in both batches.
Those in line 1
ber, 1957.

(and line 2) of Table IV were obtained in

Septem¬

Hence frogs in Table 1 and Table IV cannot be compared.

Also it is not known how long the frogs were fasted before they
arrived here from Louisiana.

A long fasting period would explain

the higher cardiac glycogen content of the controls in Table IV.
Another difference is that the latter group of frogs received
intraperitoneal saline, though Lackey (56) found this did not
alter the cardiac glycogen of rats.
The one frog that was fasted for three months (see "Results")

31

and found to have a much higher concentration of cardiac glycogen
than other animals in the same shipment is in line with the
frequently made observation that fasting elevates the heart
glycogen.
C. Effect of Beta-Hydroxybutyric Acid on Cardiac Glycogen.

Can a net synthesis of glycogen be produced from betahydroxybutyric acid?

The two hearts that had a glycogen content

of 65 and 95 mg/® after being perfused with ketone alone provide
the only suggestion of such a conversion.

When the large amount

of glycogen synthesized from glucose (588 ir 81 mg%)

is considered

plus the fact that 7 of the 9 hearts perfused with ketone alone
produced no glycogen* the values of 65 and 95 fflg> cannot be
construed as evidence that beta-hydroxybutyric acid
glycogen.

produces

Another explanation for this small amount of glycogen

must be sought.
One possibility is that the hearts were not entirely depleted
of glycogen before they were perfused.
definitely be ruled out,

Though this cannot

it is not likely when one considers that

the 7 hearts measured for glycogen content after development of
the Infarct uniformly showed no glycogen whatsoever.

Another

explanation is that glycogen was formed from precursors contained
within the myocardium.

Clark et al.

(70) found that glycogen

represented only 1/3 of the total reducing substances of the
frog heart.

Thus, though the infarct indicated the heart was

depleted of glycogen other carbohydrates or carbohydrate pre¬
cursors such as pyruvic or lactic acid may have been present.
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It is also possible that the heart formed the glycogen from certain
a.mino acids.

However, evidence against such precursors playing

a role 'are the seven hearts in Table II that demonstrated no
glycogen synthesis.

It is unfortunate that a series of frogs

perfused with just the salt solution for a period of a few hours
could not be obtained.
Further evidence against synthesis of gl,ycogen from ketone
bodies is the finding that growth hormone plus beta-hydroxybutyric acid produced no more glycogen than the hormone alone.
Nor was there any evidence of a sparing action of ketone on
glucose.

This is shown by the fact that a combination of beta-

hydroxybutyric acid with glucose produced no more glycogen than
glucose alone.
One problem that must be considered is what effect if any
the period in the anaerobic chamber had on the normal metabolism
of the heart.

Were enzyme systems destroyed or adversely affected?

Though this cannot be ruled out the excellent

synthesis of

glycogen from glucose is evidence that the enzyme systems re¬
mained intact and functioned normally.
Is it likely that perfusing the heart with acetoacetic acid
would have produced results differing from those obtained with
beta-hydroxybutyrate?

Meyer and Bow (60) found that the dog's

heart metabolized acetoacetic acid by degradation to 2 acetyl-CoA
which then entered the Kreb's cycle.
Barnes et al.

Waters et al.

(48) and

(49) found that bets,-hydroxybutyric acid was

readily oxidized by the dog heart.

The present series of experi¬

ments indicate the same is true for the frog's heart since hearts
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perfused with ketone contract much more strongly and for a.
longer time than hearts perfused with salt solution alone.

It

has also been noted (61) that butyrate is only metabolized by
animal tissues by beta-oxidation to 2 acetyl GoA.

By combining

these facts it becomes evident that beta-hydroxybutyric acid must
be oxidized to acetoacetic acid and not reduced to butyric acid
in order to be utilized by the heart.

Since the heart therefore

converts beta-hydroxybutyrate to acetoacetate it is highly un¬
likely that perfusion with the latter substance would have given
results differing from those obtained with the ketone body that
was used.

In this connection Lackey (56) found essentially the

same increase in cardiac glycogen when either beta-hydroxyhutyric
or acetoacetic acid was infused.
Would acetone have given rise to glycogen hy formation of
pyruvate?

Meyer and Bow (58, 60) found no evidence suggestive

of a conversion of acetoacetate to acetone to pjrruvate even
though, as was previously mentioned,

acetoacetic acid is decar-

boxylated to acetone by animal tissues to a small extent.

Hence

it is unlikely that acetone would have formed glycogen in these
experiments when beta-hydroxybutyric acid did not.

C, Growth Hormones

The experiments with growth hormone (

Tables III, IV

)

do not confirm the findings of Russell and coworkers in
rats that this substance increases the level of cardiac
glycogen by acting as a hormone.

As has been pointed out

under ’‘Results'* the addition of growth hormone to glucose or
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to glucose plus ketone did not increase the amount of glycogen
synthesized.

Though the hormone plus ketone produced a signi¬

ficant amount of glycogen whereas ketone alone did not, the amount
formed was the same as was obtained with the hormone alone.
Hence no evidence was found indicating that growth hormone in¬
creases glycogen synthesis from dextrose or stimulates formation
from ketones.

The in-vivo experiments (Table IV) also gave no

evidence of increased cardiac glycogen in animals injected with
growth hormone.

Insulin also was inactive.

Line 5 of Table III suggests a synthesis of glycogen from
the amino acids of growth hormone, a finding reinforced by lines
3 and 4 of the same table.

Assuming the ventricle weighed 0.5 Gm.

(rarely did it weigh slightly more),

a glycogen level of 166 mg/£

(line 3, Table IV) would mean a total glycogen content of 0.83 mgm.
Four milligrams of growth hormone per 100 cc. of salt solution
was perfused during the 6 hour period or a total of 16 mgm.
hormone since 400 cc.

of

of perfusate was used In each experiment.

This is a more than sufficient amount to explain the synthesis
of glycogen even if it is assumed the atria synthesized a similar
amount.

That growth hormone in combination with glucose did not

produce more carbohydrate than glucose alone might be interpreted
to mean that the heart will only synthesize a fixed amount of
glycogen in a limited amount of time no matter how many pre¬
cursors are available.
Why did these experiments fail to confirm Russell's finding
that growth hormone produces an increased level of cardiac gly¬
cogen?

First there is the problem of
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species difference.

Russell worked with rats;

these experiments were done with frogs.

The failure of the in-vitro experiments to confirm Russell's
findings might be attributed to growth hormone stimulating glycogenesis from some substance not present in the perfusion system.
However, this will not explain the failure to demonstrate ele¬
vated cardiac glycogen levels in the frogs injected intraperitoneally with the hormone.

In connection with the in-vivo ex¬

periments it should be noted that the control animals in line 1
of Table IV have a very high glycogen content.

Perhaps hearts

with a lower concentration of carbohydrate would, have synthesized
or stored glycogen more readily in response to growth hormone.
In both the in-vivo and the in-vitro experiments the dosage
of hormone was comparable to that used by Russell et al.
Russell and Bloom (68) concluded that growth hormone probably
increased cardiac glycogen by blocking its utilization. It may
be that under the conditions of the perfusion experiments the
heart would not readily utilize the glycogen it had synthesized
and therefore growth hormone would be unable to play a role.
would be interesting to see if growth hormone interfered with
the process of deglycogenation in the anaerobic chamber.

Also

it may be that the preparation of hormone used was inactive in
frogs.
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VI. CONCLUSIONS

As regards amphibian cardiac function the following con¬
clusions may be drawni
1) An anaerobic atmosphere plus epinephrine rapidly de¬
pletes the heart of its glycogen.

The development of the infarct

serves as an excellent indicator that the ventricle is devoid
of this carbohydrate,
2) Even when entirely depleted of glycogen the ventricle
need not resynthesize it in order to contract.
however,

Its function,

is greatly improved by the addition of a substance such

as glucose or beta-hydroxybutyrate to the perfusing fluid.
Hence, the amphibian heart appears able to utilize ketone bodies
for energy as can the mammalian heart.
In reference to the question of a net synthesis of glycogen
from ketone bodies it is concluded that under the conditions of
the present series of experiments no evidence for such a conver¬
sion could be obtained,

even though the myocardium first was

depleted of all glycogen.

Therefore these experiments add to the

generally held opinion that the animal body is unable to bring
about

such a synthesis.

Nor was any sparing effect of ketone

on glucose found.
It is also concluded that under the present experimental
conditions growth hormone,

in its role as a, hormone,

could not

be demonstrated to elevate the cardiac glycogen in the frog.
This is in contrast to the finding in the mammal (57? 68, 69)
where growth hormone does increase the store of glycogen in the
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4+

heart, the increase being due to its hormonal action.

However,

the frog's heart may have synthesized glycogen from the growth
hormone itself.
The problem of why animals in ketosis show an increase in
cardiac glycogen remains unsolved though the work by Russell et
al.

sheds much light on the problem.

Certainly the increase does

not appear to be due to a direct conversion of ketone bodies to
carbohydrate.
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VII.

SUMMARY

The hearts of American bullfrogs were first depleted of
their glj^cogen content by placing the animal in an anaerobic
environment and permitting epinephrine to drip on the exposed
heart.

It was found that the development of an "infarct11

in

the ventricle served to indicate when the myocardium was de¬
void of glycogen.

The heart was then removed from the animal and

perfused with glucose, beta-hydroxybutyric acid and a combination
of the two.

From glucose and from glucose plus ketone the heart

ventricle in six hours synthesized an amount of glycogen equal
to 50% of that found in the normal frog ventricle.

However,

no synthesis could be demonstrated from ketone alone.
The addition of growth hormone to the perfusate did not in¬
crease the synthesis of glycogen from glucose or induce any
formation from ketone.

Nor did the intraperitoneal injection of

the hormone into fasting rats result in increased levels of
glycogen in the myocardium.
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